Srinivas Akkaraju, MD, Ph.D
Independent Administrator
Dr. Srinivas Akkaraju is the Founder and Managing General Partner of Samsara BioCapital. Before establishing Samsara, he served as a General Partner at Sofinnova Ventures from 2013 to 2016, and as Managing Director at New Leaf Venture Partners from 2009 to 2013. Dr. Akkaraju also held the position of Managing Director at Panorama Capital, LLC, a private equity firm, and was a Partner at J.P. Morgan Partners, where he worked from 2001 and became a Partner in 2005. Prior to his time at J.P. Morgan Partners, Dr. Akkaraju was involved in Business and Corporate Development at Genentech, Inc. (now a part of The Roche Group), most recently as Senior Manager from 1998 to 2001.
Dr. Akkaraju earned his M.D. and Ph.D. in Immunology from Stanford University, where he was a graduate student. He also holds undergraduate degrees in Biochemistry and Computer Science from Rice University.
In addition to his leadership role at Samsara, Dr. Akkaraju serves on the boards of Scholar Rock, Mineralys Therapeutics, vTv Therapeutics, Alumis, and several private biotechnology companies. He has previously served as a director for a range of biopharma companies, including Seattle Genetics, Principia Biopharma, Chinook Therapeutics, Intercept Pharmaceuticals, Eyetech Pharmaceuticals, ZS Pharma, Synageva Biopharma Corp., Amarin Corporation, Syros and Barrier Therapeutics.